U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H22O18
Molecular Weight 634.4528
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CORILAGIN

SMILES

O[C@H]1[C@@H]2COC(=O)C3=C(C(O)=C(O)C(O)=C3)C4=C(O)C(O)=C(O)C=C4C(=O)O[C@H]1[C@H](O)[C@@H](OC(=O)C5=CC(O)=C(O)C(O)=C5)O2

InChI

InChIKey=TUSDEZXZIZRFGC-VPIGZIKCSA-N
InChI=1S/C27H22O18/c28-9-1-6(2-10(29)16(9)32)24(39)45-27-22(38)23-19(35)13(43-27)5-42-25(40)7-3-11(30)17(33)20(36)14(7)15-8(26(41)44-23)4-12(31)18(34)21(15)37/h1-4,13,19,22-23,27-38H,5H2/t13-,19-,22-,23+,27+/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H22O18
Molecular Weight 634.4528
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/1324981 | https://www.ncbi.nlm.nih.gov/pubmed/24679441 | https://www.ncbi.nlm.nih.gov/pubmed/28962079 | https://www.ncbi.nlm.nih.gov/pubmed/28791374

Corilagin is a polyphenol, ellagitannin and hydrolyzable tannin that can be isolated from a variety of plants. This compound displays the ability to inhibit squalene epoxidase, a key enzyme in cholesterol synthesis, and NFκB pathway activation and also prevent the release of TNF-α at an IC50 of 76 μM. Additional studies show that Corilagin significantly inhibits type 1 plasminogen activator inhibitor (PAI-1) in rat plasma. Also has been reported to result in an increase in plasma tissue-type plasminogen activator (tPA) which results in the thrombolytic effect of Corilagin. In other studies, Corilagin showed some other pharmaceutical activities, such as antiviral effects in vitro, antinociceptive activity, anti-hyperalgesic activity, and action of anti-tumor in hepatocellular carcinoma and ovarian cancer.

Originator

Sources: Justus Liebigs Annalen der Chemie (1951), 571, 232-7.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
40.0 µM [IC50]
4.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Intestinal alpha-glucosidase inhibitory activity and toxicological evaluation of Nymphaea stellata flowers extract.
2010-09-15
1,2,3,6-tetra-O-galloyl-beta-D-allopyranose gallotannin isolated, from Euphorbia jolkini, attenuates LPS-induced nitric oxide production in macrophages.
2010-09
Therapeutic Potential of Plants as Anti-microbials for Drug Discovery.
2010-09
Antimicrobial, antioxidant and cytotoxic activities and phytochemical screening of some yemeni medicinal plants.
2010-09
Separation and purification of hydrolyzable tannin from Geranium wilfordii Maxim by reversed-phase and normal-phase high-speed counter-current chromatography.
2010-08
Effect of Corilagin on anti-inflammation in HSV-1 encephalitis and HSV-1 infected microglias.
2010-06-10
Secondary plant substances in various extracts of the leaves, fruits, stem and bark of Caraipa densifolia Mart.
2010-06
Antioxidant activities and xanthine oxidase inhibitory effects of extracts and main polyphenolic compounds obtained from Geranium sibiricum L.
2010-04-28
Ellagitannins from Geranium potentillaefolium and G. bellum.
2010-04
Corilagin inhibits the double strand break-triggered NF-kappaB pathway in irradiated microglial cells.
2010-04
Identification of major phenolic compounds from Nephelium lappaceum L. and their antioxidant activities.
2010-03-09
Enhanced antioxidant and antityrosinase activities of longan fruit pericarp by ultra-high-pressure-assisted extraction.
2010-01-20
Structural features and biological properties of ellagitannins in some plant families of the order Myrtales.
2010-01-06
Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons.
2010-01
Chelation of Cu(II), Zn(II), and Fe(II) by tannin constituents of selected edible nuts.
2009-12-22
Native plant and microbial contributions to a negative plant-plant interaction.
2009-12
Diterpene esters and phenolic compounds from Sapium insigne (ROYLE) BENTH. ex HOOK. fil.
2009-11
Lysis of Microcystis aeruginosa with extracts from Chinese medicinal herbs.
2009-09-23
Chemical and antioxidant evaluation of Indian gooseberry (Emblica officinalis Gaertn., syn. Phyllanthus emblica L.) supplements.
2009-09
Phyllanthus urinaria extract attenuates acetaminophen induced hepatotoxicity: involvement of cytochrome P450 CYP2E1.
2009-08
Radioprotective properties of polyphenols from Phyllanthus amarus Linn.
2009-07
Gallotannin isolated from Euphorbia species, 1,2,6-tri-O-galloyl-beta-D-allose, decreases nitric oxide production through inhibition of nuclear factor-kappa>B and downstream inducible nitric oxide synthase expression in macrophages.
2009-06
Rapid identification of gallotannins from Chinese galls by matrix-assisted laser desorption/ionization time-of-flight quadrupole ion trap mass spectrometry.
2009-06
Validated HPLC method for the standardization of Phyllanthus niruri (herb and commercial extracts) using corilagin as a phytochemical marker.
2009-06
Larvicidal activity of oak Quercus infectoria Oliv. (Fagaceae) gall extracts against Anopheles stephensi Liston.
2009-06
Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo.
2009-05-15
Marker constituents of the natural antioxidant Eucalyptus leaf extract for the evaluation of food additives.
2009-05
Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1.
2009-05
Hepatoprotective activity of Eugenia jambolana Lam. in carbon tetrachloride treated rats.
2009-02
Phyllanthus urinaria increases apoptosis and reduces telomerase activity in human nasopharyngeal carcinoma cells.
2009-02
Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP.
2009-01
Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase.
2009
Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death.
2008-12
Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
2008-09
Energy product options for eucalyptus species grown as short rotation woody crops.
2008-08
Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-D-glucose) in vitro.
2008-07
Total synthesis of (-)-corilagin.
2008-06-18
Kinetics of non-catalyzed hydrolysis of tannin in high temperature liquid water.
2008-05
Exploring of Antimicrobial Activity of Triphala Mashi-an Ayurvedic Formulation.
2008-03
Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.
2008-02
Identification of urinary and intestinal bacterial metabolites of ellagitannin geraniin in rats.
2008-01-23
Antioxidant activity of some polyphenol constituents of the medicinal plant Phyllanthus amarus Linn.
2008
Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa.
2007-12
Hippomanin A from acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1 infection in vitro.
2007-12
[Synthesis and molecule recognition capability of corilagin-molecularly imprinted polymer].
2007-11
Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin.
2007-11
Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury.
2007-09-01
Plant phenolics as prolyl endopeptidase inhibitors.
2007-07
Aleppo tannin: structural analysis and salivary amylase inhibition.
2007-04-09
Assessment of the molecular weight distribution of tannin fractions through MALDI-TOF MS analysis of protein-tannin complexes.
2007-03-15
Patents

Sample Use Guides

Mice were treated with 20, 40, 80 mg/kg/day of Corilagin for consecutive four weeks
Route of Administration: Oral
RAW 264.7 cells were cultured at 2×105 cells/mL in 96-well plates and treated with various concentrations of compound 8(Corilagin) (0.4, 2.0, and 10.0 μM) in the presence of 1μg/ml LPS for 18 h. Cell viability was evaluated by the MTT methods
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:55:44 GMT 2025
Edited
by admin
on Mon Mar 31 19:55:44 GMT 2025
Record UNII
62LOS9TW6D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CORILAGIN
Common Name English
.BETA.-1-O-GALLOYL-3,6-(R)-HEXAHYDROXYDIPHENOYL-D-GLUCOSE
Preferred Name English
.BETA.-D-GLUCOPYRANOSE, CYCLIC 3,6-((1R)-4,4',5,5',6,6'-HEXAHYDROXY(1,1'-BIPHENYL)-2,2'-DICARBOXYLATE) 1-(3,4,5-TRIHYDROXYBENZOATE)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID90865084
Created by admin on Mon Mar 31 19:55:44 GMT 2025 , Edited by admin on Mon Mar 31 19:55:44 GMT 2025
PRIMARY
CAS
23094-69-1
Created by admin on Mon Mar 31 19:55:44 GMT 2025 , Edited by admin on Mon Mar 31 19:55:44 GMT 2025
PRIMARY
WIKIPEDIA
CORILAGIN
Created by admin on Mon Mar 31 19:55:44 GMT 2025 , Edited by admin on Mon Mar 31 19:55:44 GMT 2025
PRIMARY
PUBCHEM
72710702
Created by admin on Mon Mar 31 19:55:44 GMT 2025 , Edited by admin on Mon Mar 31 19:55:44 GMT 2025
PRIMARY
CHEBI
3884
Created by admin on Mon Mar 31 19:55:44 GMT 2025 , Edited by admin on Mon Mar 31 19:55:44 GMT 2025
PRIMARY
FDA UNII
62LOS9TW6D
Created by admin on Mon Mar 31 19:55:44 GMT 2025 , Edited by admin on Mon Mar 31 19:55:44 GMT 2025
PRIMARY